vs

Side-by-side financial comparison of ASPEN AEROGELS INC (ASPN) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.

ASPEN AEROGELS INC is the larger business by last-quarter revenue ($41.3M vs $31.1M, roughly 1.3× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -176.4%, a 144.3% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -66.4%). ASPEN AEROGELS INC produced more free cash flow last quarter ($13.7M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -33.9%).

Aspen Aerogels Inc is a leading manufacturer of high-performance aerogel-based insulation and thermal management materials. It serves core sectors including renewable energy, oil and gas infrastructure, aerospace, commercial construction and industrial manufacturing, with key markets across North America, Europe and Asia-Pacific. Its products are prized for superior thermal resistance, fire safety and lightweight performance for harsh operating conditions.

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

ASPN vs LFCR — Head-to-Head

Bigger by revenue
ASPN
ASPN
1.3× larger
ASPN
$41.3M
$31.1M
LFCR
Growing faster (revenue YoY)
LFCR
LFCR
+61.9% gap
LFCR
-4.5%
-66.4%
ASPN
Higher net margin
LFCR
LFCR
144.3% more per $
LFCR
-32.1%
-176.4%
ASPN
More free cash flow
ASPN
ASPN
$13.6M more FCF
ASPN
$13.7M
$25.0K
LFCR
Faster 2-yr revenue CAGR
LFCR
LFCR
Annualised
LFCR
-0.1%
-33.9%
ASPN

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ASPN
ASPN
LFCR
LFCR
Revenue
$41.3M
$31.1M
Net Profit
$-72.9M
$-10.0M
Gross Margin
-55.5%
25.0%
Operating Margin
-170.3%
-9.9%
Net Margin
-176.4%
-32.1%
Revenue YoY
-66.4%
-4.5%
Net Profit YoY
-741.7%
-52.0%
EPS (diluted)
$-0.87
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPN
ASPN
LFCR
LFCR
Q4 25
$41.3M
Q3 25
$73.0M
$31.1M
Q2 25
$78.0M
Q1 25
$78.7M
$35.2M
Q4 24
$123.1M
$32.6M
Q3 24
$117.3M
$24.7M
Q2 24
$117.8M
Q1 24
$94.5M
$35.7M
Net Profit
ASPN
ASPN
LFCR
LFCR
Q4 25
$-72.9M
Q3 25
$-6.3M
$-10.0M
Q2 25
$-9.1M
Q1 25
$-301.2M
$-14.8M
Q4 24
$11.4M
$-6.6M
Q3 24
$-13.0M
$-16.2M
Q2 24
$16.8M
Q1 24
$-1.8M
$15.6M
Gross Margin
ASPN
ASPN
LFCR
LFCR
Q4 25
-55.5%
Q3 25
28.5%
25.0%
Q2 25
32.4%
Q1 25
29.0%
28.0%
Q4 24
38.3%
34.0%
Q3 24
41.8%
21.8%
Q2 24
43.8%
Q1 24
37.2%
33.3%
Operating Margin
ASPN
ASPN
LFCR
LFCR
Q4 25
-170.3%
Q3 25
-4.6%
-9.9%
Q2 25
-6.6%
Q1 25
-380.2%
-25.7%
Q4 24
12.0%
-6.0%
Q3 24
14.8%
-46.9%
Q2 24
17.0%
Q1 24
2.6%
-2.5%
Net Margin
ASPN
ASPN
LFCR
LFCR
Q4 25
-176.4%
Q3 25
-8.7%
-32.1%
Q2 25
-11.6%
Q1 25
-382.7%
-42.0%
Q4 24
9.2%
-20.2%
Q3 24
-11.1%
-65.7%
Q2 24
14.3%
Q1 24
-1.9%
43.8%
EPS (diluted)
ASPN
ASPN
LFCR
LFCR
Q4 25
$-0.87
Q3 25
$-0.08
$-0.29
Q2 25
$-0.11
Q1 25
$-3.67
$-0.47
Q4 24
$0.15
$-0.25
Q3 24
$-0.17
$-0.53
Q2 24
$0.21
Q1 24
$-0.02
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPN
ASPN
LFCR
LFCR
Cash + ST InvestmentsLiquidity on hand
$156.9M
$18.9M
Total DebtLower is stronger
$65.5M
$136.0M
Stockholders' EquityBook value
$235.5M
$-10.5M
Total Assets
$406.7M
$235.2M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPN
ASPN
LFCR
LFCR
Q4 25
$156.9M
Q3 25
$150.7M
$18.9M
Q2 25
$167.6M
Q1 25
$192.0M
$5.4M
Q4 24
$220.9M
$9.5M
Q3 24
$113.5M
Q2 24
$91.4M
Q1 24
$101.5M
Total Debt
ASPN
ASPN
LFCR
LFCR
Q4 25
$65.5M
Q3 25
$70.1M
$136.0M
Q2 25
$77.3M
Q1 25
$95.4M
$124.9M
Q4 24
$95.0M
$111.3M
Q3 24
$93.7M
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
ASPN
ASPN
LFCR
LFCR
Q4 25
$235.5M
Q3 25
$305.7M
$-10.5M
Q2 25
$308.8M
Q1 25
$314.8M
$2.2M
Q4 24
$614.7M
$15.4M
Q3 24
$507.6M
$-3.9M
Q2 24
$517.8M
Q1 24
$491.2M
$17.7M
Total Assets
ASPN
ASPN
LFCR
LFCR
Q4 25
$406.7M
Q3 25
$491.4M
$235.2M
Q2 25
$525.1M
Q1 25
$555.0M
$237.7M
Q4 24
$895.1M
$255.4M
Q3 24
$782.6M
$246.8M
Q2 24
$748.6M
Q1 24
$698.0M
$246.2M
Debt / Equity
ASPN
ASPN
LFCR
LFCR
Q4 25
0.28×
Q3 25
0.23×
Q2 25
0.25×
Q1 25
0.30×
56.05×
Q4 24
0.15×
7.20×
Q3 24
0.18×
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPN
ASPN
LFCR
LFCR
Operating Cash FlowLast quarter
$16.1M
$1.8M
Free Cash FlowOCF − Capex
$13.7M
$25.0K
FCF MarginFCF / Revenue
33.1%
0.1%
Capex IntensityCapex / Revenue
6.0%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.6M
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPN
ASPN
LFCR
LFCR
Q4 25
$16.1M
Q3 25
$15.0M
$1.8M
Q2 25
$-3.9M
Q1 25
$5.6M
$1.2M
Q4 24
$35.7M
$-6.1M
Q3 24
$20.8M
$-613.0K
Q2 24
$6.8M
Q1 24
$-17.7M
$-1.4M
Free Cash Flow
ASPN
ASPN
LFCR
LFCR
Q4 25
$13.7M
Q3 25
$5.9M
$25.0K
Q2 25
$-16.8M
Q1 25
$-7.4M
$-4.3M
Q4 24
$20.9M
$-8.6M
Q3 24
$-50.0K
$-4.0M
Q2 24
$-18.0M
Q1 24
$-43.6M
$-7.8M
FCF Margin
ASPN
ASPN
LFCR
LFCR
Q4 25
33.1%
Q3 25
8.1%
0.1%
Q2 25
-21.6%
Q1 25
-9.4%
-12.1%
Q4 24
17.0%
-26.3%
Q3 24
-0.0%
-16.3%
Q2 24
-15.3%
Q1 24
-46.1%
-21.8%
Capex Intensity
ASPN
ASPN
LFCR
LFCR
Q4 25
6.0%
Q3 25
12.5%
5.6%
Q2 25
16.5%
Q1 25
16.5%
15.5%
Q4 24
12.0%
7.5%
Q3 24
17.7%
13.9%
Q2 24
21.1%
Q1 24
27.4%
17.8%
Cash Conversion
ASPN
ASPN
LFCR
LFCR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.14×
Q3 24
Q2 24
0.41×
Q1 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPN
ASPN

Energy Industrial$14.5M35%
Other$13.9M34%
Thermal Barrier$12.9M31%

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

Related Comparisons